Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2019 Jul;68(7):1200-1209.
doi: 10.1136/gutjnl-2017-315335. Epub 2018 Jun 1.

Non-superiority of lumen-apposing metal stents over plastic stents for drainage of walled-off necrosis in a randomised trial

Affiliations
Randomized Controlled Trial

Non-superiority of lumen-apposing metal stents over plastic stents for drainage of walled-off necrosis in a randomised trial

Ji Young Bang et al. Gut. 2019 Jul.

Abstract

Objective: Although lumen-apposing metal stents (LAMS) are increasingly used for drainage of walled-off necrosis (WON), their advantage over plastic stents is unclear. We compared efficacy of LAMS and plastic stents for WON drainage.

Design: Patients with WON were randomised to endoscopic ultrasound-guided drainage using LAMS or plastic stents. Primary outcome was comparing total number of procedures to achieve treatment success defined as symptom relief in conjunction with WON resolution on CT at 6 months. Secondary outcomes were treatment success, procedure duration, clinical/stent-related adverse events, readmissions, length of hospital stay (LOS) and costs.

Results: 60 patients underwent LAMS (n=31) or plastic stent (n=29) placement. There was no significant difference in total number of procedures performed (median 2 (range 2-7) LAMS vs 3 (range 2-7) plastic, p=0.192), treatment success, clinical adverse events, readmissions, LOS and overall treatment costs between cohorts. Although procedure duration was shorter (15 vs 40 min, p<0.001), stent-related adverse events (32.3% vs 6.9%, p=0.01) and procedure costs (US$12 155 vs US$6609, p<0.001) were higher with LAMS. Significant stent-related adverse events were observed ≥3 weeks postintervention in LAMS cohort. Interim audit resulted in protocol amendment where CT scan was obtained at 3 weeks postintervention followed by LAMS removal if WON had resolved. After protocol amendment, there was no significant difference in adverse events between cohorts.

Conclusion: Except for procedure duration, there was no significant difference in treatment outcomes between LAMS and plastic stents. To minimise adverse events with LAMS, patients should undergo follow-up imaging and stent removal at 3 weeks if WON has resolved.

Trial registration number: NCT02685865.

Keywords: endoscopic ultrasonography; pancreatic disease.

PubMed Disclaimer

Conflict of interest statement

Competing interests: SV: Consultant for Olympus Medical Systems Corporation and Boston Scientific Corporation. RH: Consultant for Olympus Medical Systems Corporation and Boston Scientific Corporation.

Figures

Figure 1
Figure 1
Consort flow diagram of patient enrolment. EUS, endoscopic ultrasound; WON, walled-off necrosis.
Figure 2
Figure 2
The lumen-apposing metal stents (LAMS) has completely migrated into the walled-off necrosis (WON) cavity and cannot be visualised on endoscopy (A). Endoscopic image of LAMS almost migrating inside the WON cavity (B).
Figure 3
Figure 3
Endoscopic ultrasound (EUS) image of interlacing vessels within the distal flange of the lumen-apposing metal stents (LAMS) (A). Endoscopic image of LAMS, which was placed 5 weeks previously in the duodenal bulb (B). The LAMS can be seen causing biliary stricture on EUS due to external compression on the common bile duct (C).
Figure 4
Figure 4
Lumen-apposing metal stents (LAMS) was placed via the transgastric route to drain the walled-off necrosis (A). The patient presented 16 days postprocedure with abdominal pain, where a CT showed that the LAMS had migrated out of the transmural tract and into the pylorus resulting in gastric outlet obstruction (B). The LAMS could no longer be seen in the gastric lumen on endoscopy as it had migrated further distally into the jejunum (C). Repeat CT showed that the LAMS had now migrated into the descending colon (D) and finally into the rectosigmoid junction (E), where it was removed via flexible sigmoidoscopy.

Comment in

References

    1. Varadarajulu S, Bang JY, Sutton BS, et al. . Equal efficacy of endoscopic and surgical cystogastrostomy for pancreatic pseudocyst drainage in a randomized trial. Gastroenterology 2013;145:583–90. 10.1053/j.gastro.2013.05.046 - DOI - PubMed
    1. Bang JY, Wilcox CM, Trevino JM, et al. . Relationship between stent characteristics and treatment outcomes in endoscopic transmural drainage of uncomplicated pancreatic pseudocysts. Surg Endosc 2014;28:2877–83. 10.1007/s00464-014-3541-7 - DOI - PubMed
    1. Baron TH, Harewood GC, Morgan DE, et al. . Outcome differences after endoscopic drainage of pancreatic necrosis, acute pancreatic pseudocysts, and chronic pancreatic pseudocysts. Gastrointest Endosc 2002;56:7–17. 10.1067/mge.2002.125106 - DOI - PubMed
    1. Varadarajulu S, Bang JY, Phadnis MA, et al. . Endoscopic transmural drainage of peripancreatic fluid collections: outcomes and predictors of treatment success in 211 consecutive patients. J Gastrointest Surg 2011;15:2080–8. 10.1007/s11605-011-1621-8 - DOI - PubMed
    1. Gluck M, Ross A, Irani S, et al. . Dual modality drainage for symptomatic walled-off pancreatic necrosis reduces length of hospitalization, radiological procedures, and number of endoscopies compared to standard percutaneous drainage. J Gastrointest Surg 2012;16:248–57. 10.1007/s11605-011-1759-4 - DOI - PubMed

Publication types

MeSH terms

Associated data